Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60
NCT02234037
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
Slow accrual
Conditions
Leukemia
Interventions
DRUG:
Decitabine
BEHAVIORAL:
Exercise
Sponsor
Emory University